{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:51:18Z","timestamp":1792144278360,"version":"4.4.0"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T00:00:00Z","timestamp":1637884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>\n                    <jats:bold>Objective:<\/jats:bold>\n                    This study aims to identify differentially expressed salivary miRNAs and validate the diagnostic potential for idiopathic Parkinson's disease (PD). Also, the disease specificity of candidate miRNAs was evaluated between PD, multiple system atrophy (MSA), and essential tremor (ET).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Methods:<\/jats:bold>\n                    We collected salivary samples from 50 PD, 20 ET, and 20 MSA patients, as well as 30 healthy controls (HCs). In the discovery phase, salivary miRNA microarray analysis was performed.\n                    <jats:italic>In-silico<\/jats:italic>\n                    analysis was used to investigate the target genes of differentially expressed miRNAs and clustered pathways. In validation phase, RT-qPCR was performed with samples from 30 PD patients and 30 HCs. Subsequently, we investigated candidate miRNAs in all recruited subjects. Receiver operating characteristic curve and Spearman correlation analysis was performed to determine diagnostic usefulness.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Results:<\/jats:bold>\n                    We identified 43 miRNAs that were differentially expressed between 5 PD patients and 5 HCs by miRNA microarray analysis. Computational analysis revealed the target genes were clustered in the pathways associated with ubiquitin protein ligase activity. The result of RT-qPCR showed that the miR-29a-3p and miR-29c-3p were found to be significantly downregulated (\n                    <jats:italic>p<\/jats:italic>\n                    = 0.004,\n                    <jats:italic>p<\/jats:italic>\n                    = 0.027), whereas the miR-6756-5p was significantly upregulated in 30 PD patients compared with 30 HCs (\n                    <jats:italic>p<\/jats:italic>\n                    = 0.032). The miR-29a-3p expression level in PD patients was significantly lower than ET patients (\n                    <jats:italic>p<\/jats:italic>\n                    = 0.035), but higher than MSA patients (\n                    <jats:italic>p<\/jats:italic>\n                    &amp;lt; 0.0001). The diagnostic efficacy reached a little higher when the combination of miR-29a-3p and miR-29c-3p.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Conclusion:<\/jats:bold>\n                    The miRNA combination of salivary miR-29a-3p and miR-29c-3p has potential to be a diagnostic biomarker for idiopathic PD.\n                  <\/jats:p>","DOI":"10.3389\/fneur.2021.738530","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T23:15:31Z","timestamp":1638314131000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":32,"title":["Profiling of Differentially Expressed MicroRNAs in Saliva of Parkinson's Disease Patients"],"prefix":"10.3389","volume":"12","author":[{"given":"Yanyan","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunchuang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luhua","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwen","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,11,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1212\/WNL.0000000000002350","article-title":"Accuracy of clinical diagnosis of Parkinson disease: A systematic review and meta-analysis","volume":"86","author":"Rizzo","year":"2016","journal-title":"Neurology."},{"key":"B2","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s12264-019-00433-1","article-title":"Biomarkers for Parkinson's disease: how good are they?","volume":"36","author":"Li","year":"2020","journal-title":"Neurosci Bull."},{"key":"B3","doi-asserted-by":"publisher","first-page":"5649","DOI":"10.3390\/ijms20225649","article-title":"Role of microRNAs in Parkinson's disease","volume":"20","author":"Goh","year":"2019","journal-title":"Int J Mol Sci."},{"key":"B4","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3389\/fnmol.2016.00128","article-title":"Role of microRNAs in the regulation of alpha-synuclein expression: a systematic review","volume":"9","author":"Recasens","year":"2016","journal-title":"Front Mol Neurosci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/mds.27928","article-title":"Circulating Brain-enriched MicroRNAs for detection and discrimination of idiopathic and genetic Parkinson's disease","volume":"35","author":"Ravanidis","year":"2020","journal-title":"Mov Disord."},{"key":"B6","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1002\/ana.25490","article-title":"Meta-analyses identify differentially expressed micrornas in Parkinson's disease","volume":"85","author":"Schulz","year":"2019","journal-title":"Ann Neurol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13041-019-0471-2","article-title":"Identification of plasma microRNA expression changes in multiple system atrophy and Parkinson's disease","volume":"12","author":"Uwatoko","year":"2019","journal-title":"Mol Brain."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1002\/mds.28143","article-title":"MicroRNA deregulation in blood serum identifies multiple system atrophy altered pathways","volume":"35","author":"Perez-Soriano","year":"2020","journal-title":"Mov Disord."},{"key":"B9","doi-asserted-by":"publisher","first-page":"232","DOI":"10.3389\/fnagi.2017.00232","article-title":"MicroRNA-4639 Is a regulator of DJ-1 expression and a potential early diagnostic marker for Parkinson's disease","volume":"9","author":"Chen","year":"2017","journal-title":"Front Aging Neurosci."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.21037\/tlcr-19-530","article-title":"Salivary microRNAs show potential as biomarkers for early diagnosis of malignant pleural effusion","volume":"9","author":"Yang","year":"2020","journal-title":"Transl Lung Cancer Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.bj.2018.03.004","article-title":"Salivary biomarkers for the diagnosis and monitoring of neurological diseases","volume":"41","author":"Farah","year":"2018","journal-title":"Biomed J."},{"key":"B12","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3389\/fnagi.2020.00210","article-title":"Increased salivary microRNAs that regulate DJ-1 gene expression as potential markers for Parkinson's disease","volume":"12","author":"Chen","year":"2020","journal-title":"Front Aging Neurosci."},{"key":"B13","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1002\/mds.27935","article-title":"Salivary microR-153 and microR-223 levels as potential diagnostic biomarkers of idiopathic Parkinson's disease","volume":"35","author":"Cressatti","year":"2020","journal-title":"Mov Disord."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.parkreldis.2017.06.006","article-title":"Hyperechogenicity of substantia nigra for differential diagnosis of Parkinson's disease: a meta-analysis","volume":"42","author":"Shafieesabet","year":"2017","journal-title":"Parkinsonism Relat Disord."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov Disord."},{"key":"B16","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/mds.27121","article-title":"Consensus Statement on the classification of tremors from the task force on tremor of the International Parkinson and Movement Disorder Society","volume":"33","author":"Bhatia","year":"2018","journal-title":"Mov Disord."},{"key":"B17","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","article-title":"Second consensus statement on the diagnosis of multiple system atrophy","volume":"71","author":"Gilman","year":"2008","journal-title":"Neurology."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1002\/mds.23429","article-title":"Systematic review of levodopa dose equivalency reporting in Parkinson's disease","volume":"25","author":"Tomlinson","year":"2010","journal-title":"Mov Disord."},{"key":"B19","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1021\/acschemneuro.8b00520","article-title":"Advances in the research of risk factors and prodromal biomarkers of Parkinson's disease","volume":"10","author":"Xie","year":"2019","journal-title":"ACS Chem Neurosci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"315","DOI":"10.14336\/AD.2019.0324","article-title":"Rapid eye movement sleep behavior disorder and neurodegenerative diseases: an update","volume":"11","author":"Zhang","year":"2020","journal-title":"Aging Dis."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1093\/brain\/awab156","article-title":"The role of gut dysbiosis in Parkinson's disease: mechanistic insights andtherapeutic options","volume":"144","author":"Wang","year":"2021","journal-title":"Brain"},{"key":"B22","doi-asserted-by":"publisher","first-page":"bbaa244","DOI":"10.1093\/bib\/bbaa244","article-title":"Multimodal analysis of gene expression from postmortem brains and blood identifies synaptic vesicle trafficking genes to be associated with Parkinson's disease","volume":"22","author":"Gao","year":"2021","journal-title":"Brief Bioinform."},{"key":"B23","doi-asserted-by":"publisher","first-page":"692","DOI":"10.14336\/AD.2019.0814","article-title":"Implications of long non-coding RNAs in age-altered proteostasis","volume":"11","author":"Catana","year":"2020","journal-title":"Aging Dis."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.14336\/AD.2020.0309","article-title":"Circular RNAs: promising biomarkers for age-related diseases","volume":"11","author":"Pan","year":"2020","journal-title":"Aging Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.14336\/AD.2021.0115","article-title":"tRNA-derived fragments as New Hallmarks of Aging and Age-related Diseases","volume":"12","author":"Yuan","year":"2021","journal-title":"Aging Dis."},{"key":"B26","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1136\/jnnp-2019-322338","article-title":"Parkinson's disease: etiopathogenesis and treatment","volume":"91","author":"Jankovic","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B27","doi-asserted-by":"publisher","first-page":"559","DOI":"10.14336\/AD.2019.0612","article-title":"Oxyphylla A promotes degradation of alpha-synuclein for neuroprotection via activation of immunoproteasome","volume":"11","author":"Zhou","year":"2020","journal-title":"Aging Dis."},{"key":"B28","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.parkreldis.2015.11.014","article-title":"Identification of a panel of five serum miRNAs as a biomarker for Parkinson's disease","volume":"22","author":"Ding","year":"2016","journal-title":"Parkinsonism Relat Disord."},{"key":"B29","doi-asserted-by":"publisher","first-page":"102078","DOI":"10.1016\/j.npep.2020.102078","article-title":"An integrated approach to unravel a putative crosstalk network in Alzheimer's disease and Parkinson's disease","volume":"83","author":"Bisht","year":"2020","journal-title":"Neuropeptides."},{"key":"B30","doi-asserted-by":"publisher","first-page":"841","DOI":"10.3390\/cells9040841","article-title":"The promise and challenges of developing miRNA-based therapeutics for Parkinson's disease","volume":"9","author":"Titze-De-Almeida","year":"2020","journal-title":"Cells."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1261\/rna.044008.113","article-title":"Brain-specific knockdown of miR-29 results in neuronal cell death and ataxia in mice","volume":"20","author":"Roshan","year":"2014","journal-title":"RNA."},{"key":"B32","doi-asserted-by":"publisher","first-page":"4281","DOI":"10.1073\/pnas.1909814117","article-title":"Decision between mitophagy and apoptosis by Parkin via VDAC1 ubiquitination","volume":"117","author":"Ham","year":"2020","journal-title":"Proc Natl Acad Sci USA."},{"key":"B33","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1111\/1440-1681.13212","article-title":"MiR-29c protects against inflammation and apoptosis in Parkinson's disease model in vivo and in vitro by targeting SP1","volume":"47","author":"Wang","year":"2020","journal-title":"Clin Exp Pharmacol Physiol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41531-021-00159-w","article-title":"\u201cHot cross bun\u201d is a potential imaging marker for the severity of cerebellar ataxia in MSA-C","volume":"7","author":"Zhu","year":"2021","journal-title":"NPJ Parkinsons Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"13518","DOI":"10.18632\/aging.103458","article-title":"Association of the serum microRNA-29 family with cognitive impairment in Parkinson's disease","volume":"12","author":"Han","year":"2020","journal-title":"Aging."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.738530\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T23:15:35Z","timestamp":1638314135000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2021.738530\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,26]]},"references-count":35,"alternative-id":["10.3389\/fneur.2021.738530"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2021.738530","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,26]]},"article-number":"738530"}}